110P Real-world evaluation of pembrolizumab monotherapy for previously treated PD-L1 positive (TPS>1%) advanced NSCLC in France M. Pérol,X. Quantin,H. Lena,T. Filleron,C. Chouaid,C. Audigier Valette, C. Kaderbhai, G. Chenuc, M. Santorelli, L. Bensimon,T. Burke,G. Simon,A-L. Martin, D. Debieuvre, R. Gervais,R. Schott,M. Carton, C. Courtinard,N. GirardJournal of Thoracic Oncology（2021）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
